Medistim ASA (OSTO:MEDIO) Ending Cash Position: kr100.2 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MEDIO Medistim ASA OSTO:MEDIO
98 GF Score
Price kr265.00
GF Value kr255.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Medistim ASA Ending Cash Position?

Medistim ASA OSTO:MEDIO 98 Ending Cash Position is kr100.2 Mil as of Jun. 2026. GuruFocus rates OSTO:MEDIO with a GF Score™ of 98/100 and a GF Value™ of kr255.14 (Fairly Valued). The stock has 4 warning signs investors should review.

Medistim ASA's Ending Cash Position for the quarter that ended in Jun. 2026 was kr100.2 Mil.

Medistim ASA's quarterly Ending Cash Position declined from Dec. 2025 (kr212.1 Mil) to Mar. 2026 (kr209.8 Mil) and declined from Mar. 2026 (kr209.8 Mil) to Jun. 2026 (kr100.2 Mil).

Medistim ASA's annual Ending Cash Position increased from Dec. 2023 (kr153.9 Mil) to Dec. 2024 (kr179.2 Mil) and increased from Dec. 2024 (kr179.2 Mil) to Dec. 2025 (kr212.1 Mil).

Medistim ASA Ending Cash Position Related Terms

Medistim ASA Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Medistim ASA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistim ASA Ending Cash Position Chart

Medistim ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 129.49 152.64 153.87 179.21 212.09

Medistim ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.35 157.66 212.09 209.78 100.15
OSTO:MEDIO
98GF Score
Medistim ASA OSTO:MEDIO
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistim ASA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Medistim ASA's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=179.21+32.878
=212.1

Medistim ASA's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=209.784+-109.634
=100.2

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of kr100.2 Mil mean?
Medistim ASA (OSTO:MEDIO) has a Ending Cash Position of kr100.2 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medistim ASA and its competitors.
Is Medistim ASA's Ending Cash Position too high?
Medistim ASA's current Ending Cash Position is kr100.2 Mil. Overall, Medistim ASA has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Ending Cash Position compare to ABT and SYK?
Medistim ASA's Ending Cash Position of kr100.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medistim ASA and its competitors. Medistim ASA's current Ending Cash Position is kr100.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Based on GuruFocus' analysis, Medistim ASA (OSTO:MEDIO) is currently considered Fairly Valued. The stock's GF Value™ is kr255.14, compared to a current price of kr265.00 — trading 3.9% above its estimated fair value. The current Ending Cash Position is kr100.2 Mil. Medistim ASA's overall GF Score™ is 98/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Medistim ASA (OSTO:MEDIO), the current Ending Cash Position is kr100.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medistim ASA (OSTO:MEDIO) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be overvalued. The current stock price of kr265.00 is trading 3.9% above its estimated GF Value™ of kr255.14. GuruFocus considers Medistim ASA to be Fairly Valued.

Key valuation signals for OSTO:MEDIO:

  • Ending Cash Position: kr100.2 Mil
  • GF Value™: kr255.14 vs. price of kr265.00 (3.9% above fair value)
  • GF Score™: 98/100 with 4 warning signs

No single metric tells the full story. See the OSTO:MEDIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
98GF Score

Get the complete analysis for OSTO:MEDIO

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr265.00
Price
kr255.14
GF Value